Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate the long-term outcome of chronic total occlusion (CTO) patients underwent contemporary percutaneous coronary intervention (PCI) techniques, we design this single-center, large-sample, prospective registry with five-year clinical follow-up, based on the intravascular ultrasound (IVUS) finding.
The study plan to include the patients with a CTO lesion in one of the three main epicardial coronary artery (diameter more than 2.5 mm) as the only target lesion. The CTO lesion is defined as 0 grade of thrombolysis in myocardial infarction (TIMI) flow with evidence of occlusion duration more than 3 months. All the PCI procedure will be performed by a group of certified operators in Fuwai Hospital, Beijing, China. All patients evaluate IVUS with automatic pullback (Opticross, Boston Scientific, US) performed after wire crossing. All the included patients are planned for five-year follow-up.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Target vessel revascularization | Any ischemic driven revascularization of the target vessel | 5-year follow-up after index PCI |
| Measure | Description | Time Frame |
|---|---|---|
| All-cause death | Any cause of death | Within the first 1 month after PCI and during the 5-year follow-up |
| Cardiac death | Cardiac death |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
CTO Patients who underwent PCI with contemporary CTO techniques by certified operators in Fuwai Hospital.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bo Xu | Fuwai Hospital, Catheter Lab | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Lei Song | Beijing | Beijing Municipality | 100037 | China |
Not provided
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Within the first 1 month after PCI and during the 5-year follow-up |
| Myocardial infarction | Any myocardial infarction including perioperative MI | Within the first 1 month after PCI and during the 5-year follow-up |
| Stroke | Ischemic or hemorrhagic stroke | Within the first 1 month after PCI and during the 5-year follow-up |
| Major adverse cardiac and cerebrovascular events (MACCE) | Including all-cause death, myocardial infarction, stroke or any target vessel revascularization | Within the first 1 month after PCI and during the 5-year follow-up |